Literature DB >> 22399319

Consequences of fuzziness in the NFκB/IκBα interaction.

Elizabeth A Komives1.   

Abstract

This chapter provides a short review of various biophysical experiments that have been applied to the inhibitor of kappa B, IκBα and its binding partner, nuclear factor kappa B, or NFκB. The picture that emerges from amide hydrogen/deuterium exchange, NMR and binding kinetics experiments is one in which parts of both proteins are "fuzzy" in the free-state and some parts remain "fuzzy" in the NFκB-IκBα complex. The NFκB family of transcription factors responds to inflammatory cytokines with rapid transcriptional activation, in which NFκB enters the nucleus and binds DNA. Just as rapidly as transcription is activated, it is subsequently repressed by newly synthesized IκBα?that also enters the nucleus and removes NFκB from the DNA. Because IκBα?is an ankyrin repeat protein, it's "fuzziness" can be controlled by mutagenesis to stabilized the folded state. Experimental comparison with such stabilized mutants helps provide evidence that much of the system control depends on the "fuzziness" of IκBα.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399319      PMCID: PMC3603378          DOI: 10.1007/978-1-4614-0659-4_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  41 in total

Review 1.  Circuitry of nuclear factor kappaB signaling.

Authors:  Alexander Hoffmann; David Baltimore
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

2.  Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities.

Authors:  Alexander Hoffmann; Thomas H Leung; David Baltimore
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

3.  Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells.

Authors:  E B Traenckner; P A Baeuerle
Journal:  J Cell Sci Suppl       Date:  1995

4.  A fourth IkappaB protein within the NF-kappaB signaling module.

Authors:  Soumen Basak; Hana Kim; Jeffrey D Kearns; Vinay Tergaonkar; Ellen O'Dea; Shannon L Werner; Chris A Benedict; Carl F Ware; Gourisankar Ghosh; Inder M Verma; Alexander Hoffmann
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

5.  NF-kappaB dictates the degradation pathway of IkappaBalpha.

Authors:  Erika Mathes; Ellen L O'Dea; Alexander Hoffmann; Gourisankar Ghosh
Journal:  EMBO J       Date:  2008-04-10       Impact factor: 11.598

6.  The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation.

Authors:  T Huxford; D B Huang; S Malek; G Ghosh
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

7.  Structure of an IkappaBalpha/NF-kappaB complex.

Authors:  M D Jacobs; S C Harrison
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

8.  Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.

Authors:  F E Chen; D B Huang; Y Q Chen; G Ghosh
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

9.  Role of the hydrophobic effect in stability of site-specific protein-DNA complexes.

Authors:  J H Ha; R S Spolar; M T Record
Journal:  J Mol Biol       Date:  1989-10-20       Impact factor: 5.469

10.  The IkappaBalpha/NF-kappaB complex has two hot spots, one at either end of the interface.

Authors:  Simon Bergqvist; Gourisankar Ghosh; Elizabeth A Komives
Journal:  Protein Sci       Date:  2008-09-29       Impact factor: 6.725

View more
  2 in total

1.  Regulation and function of nuclear IκBα in inflammation and cancer.

Authors:  Ivana Vancurova; Ales Vancura
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

2.  Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation.

Authors:  Sowjanya Thatikonda; Venkatesh Pooladanda; Dilep Kumar Sigalapalli; Chandraiah Godugu
Journal:  Cell Death Dis       Date:  2020-01-10       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.